Cohance Lifesciences Limited (BOM:543064)
India
· Delayed Price · Currency is INR 494.15
+61.45 (14.20%)
At close: Apr 28, 2026
Cohance Lifesciences Market Cap
Cohance Lifesciences has a market cap or net worth of 188.72 billion as of April 28, 2026. Its market cap has decreased by -31.86% in one year.
Market Cap
188.72B
Enterprise Value
190.59B
Revenue
10.79B
Ranking
n/a
PE Ratio
311.21
Stock Price
494.15
Market Cap Chart
Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 188.72B, an increase of 559,818.02%. That is a compound annual growth rate of 307.82%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caplin Point Laboratories | 130.50B |
| Jubilant Pharmova | 149.60B |
| Rubicon Research | 154.65B |
| Granules India | 170.76B |
| CORONA Remedies | 99.90B |
| Viyash Scientific | 90.17B |
| AstraZeneca Pharma India | 212.54B |
| Procter & Gamble Health | 85.33B |